Abstract:Graphical and Lay Summary The heterogenous production conditions in large‐scale bioreactors cause scale‐up problems, such as reduced biomass or product yield, to occur during bioprocesses. In this study, we designed a two‐compartment scale‐down reactor and used it to simulate large‐scale heterogenous production conditions, allowing us to understand these scale‐up problems and identify solutions at the laboratory scale. A computational fluid dynamics simulation was used for the design and detailed characterization of the scale‐down setup, as this simulation can model the production scale and support improved bioprocess scale‐up in the future. The scale‐up of bioprocesses remains one of the major obstacles in the biotechnology industry. Scale‐down bioreactors have been identified as valuable tools to investigate the heterogeneities observed in large‐scale tanks at the laboratory scale. Additionally, computational fluid dynamics (CFD) simulations can be used to gain information about fluid flow in tanks used for production. Here, we present the rational design and comprehensive characterization of a scale‐down setup, in which a flexible and modular plug‐flow reactor was connected to a stirred‐tank bioreactor. With the help of CFD using the realizable k‐ε model, the mixing time difference between a 20 and 4000 L bioreactor was evaluated and used as scale‐down criterion. CFD simulations using a shear stress transport (SST) k‐ω turbulence model were used to characterize the plug‐flow reactor in more detail, and the model was verified using experiments. Additionally, the model was used to simulate conditions where experiments technically could not be performed due to sensor limitations. Nevertheless, verification is difficult in this case as well. This was the first time a scale‐down setup was tested on high‐cell‐density Escherichia coli cultivations to produce industrially relevant antigen‐binding fragments (Fab). Biomass yield was reduced by 11% and specific product yield was reduced by 20% during the scale‐down cultivations. Additionally, the intracellular Fab fraction was increased by using the setup. The flexibility of the introduced scale‐down setup in combination with CFD simulations makes it a valuable tool for investigating scale effects at the laboratory scale. More information about the large scale is still necessary to further refine the setup and to speed up bioprocess scale‐up in the future.

Development of a high‐throughput scale‐down model in Ambr® 250 HT for plasmid DNA fermentation processes

Converting a Mab Downstream Process from Batch to Continuous Using Process Modeling and Process Analytical Technology.

Development and Qualification of a Scale-Down Mammalian Cell Culture Model and Application in Design Space Development by Definitive Screening Design

Development and qualification of 3 L scale‐down model for large scale vaccine process on vero cell culture using microcarriers

An in-silico analysis of hydrodynamics and gas mass transfer characteristics in scale-down models for mammalian cell cultures

A novel scale‐down mimic of perfusion cell culture using sedimentation in an automated microbioreactor (SAM)

Computational fluid dynamics based digital twins of fixed bed bioreactors validate scaling principles for recombinant adeno-associated virus gene therapy manufacturing

Computational fluid dynamics simulation improves the design and characterization of a plug‐flow‐type scale‐down reactor for microbial cultivation processes

Perfusion Process Intensification for Lentivirus Production Using a Novel Scale‐Down Model

Developing the biofacility of the future based on continuous processing and single-use technology

Process Optimization for the Rapid Production of Adenoviral Vectors for Clinical Trials in a Disposable Bioreactor System.

Model uncertainty-based evaluation of process strategies during scale-up of biopharmaceutical processes

A protocol to transfer a fed‐batch platform process into semi‐perfusion mode: The benefit of automated small‐scale bioreactors compared to shake flasks as scale‐down model

Downscaling screening cultures in a multifunctional bioreactor array‐on‐a‐chip for speeding up optimization of yeast‐based lactic acid bioproduction

Mini Bubble Columns for Miniaturizing Scale‐Down

Innovative fixed bed bioreactor platform: Enabling linearly scalable adherent cell biomanufacturing with real-time biomass prediction from nutrient consumption

Scale‐up of an intensified bioprocess for the expansion of bovine adipose‐derived stem cells (bASCs) in stirred tank bioreactors

Scaling Fed-Batch and Perfusion Antibody Production Processes in Geometrically Dissimilar Stirred Bioreactors

Development of bioreactor scale‐down model using orthogonal projections to latent structures method and CO2 supplementation

A methodical approach to ultra-scale-down of process sequences: application to casein removal from the milk of transgenic animals

CHO cell productivity improvement by genome-scale modeling and pathway analysis: Application to feed supplements